Cardiotoxicity in Oncology Guidelines: Discrepancies Do Matter - 30/05/24
Doi : 10.1016/j.hlc.2024.02.007
Sean Tan, MBBS a, b, 1, ⁎ 
, Zainel Kader, MD b, 1, Daphne Day, MBBS c, d, Daniel Chen, BMed e, f, Stephen J. Nicholls, MBBS, PhD a, b, Satish Ramkumar, MBBS, PhD a, b
, Zainel Kader, MD b, 1, Daphne Day, MBBS c, d, Daniel Chen, BMed e, f, Stephen J. Nicholls, MBBS, PhD a, b, Satish Ramkumar, MBBS, PhD a, b a Victorian Heart Institute, Monash University, Melbourne, Vic, Australia
b Monash Heart, Victorian Heart Hospital, Melbourne, Vic, Australia
c School of Clinical Sciences at Monash Health, Monash University, Melbourne, Vic, Australia
d Department of Oncology, Monash Health, Melbourne, Vic, Australia
e Prince of Wales and St George Hospitals, South Eastern Sydney Local Health District, Sydney, NSW, Australia
f Hatter Cardiovascular Institute, University College of London, London, UK
∗Correspondence author at: Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, Vic, AustraliaVictorian Heart InstituteMonash University631 Blackburn RoadClaytonVicAustralia
Keywords : Cardio-oncology, Challenges, Guidelines, Definition
Le texte complet de cet article est disponible en PDF.
Plan
© 2024
Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 33 - N° 5
P. 553-557 - mai 2024 Retour au numéro
Article précédent
- Cardio-Oncology—Beyond Anthracyclines and Ejection Fraction
- Paul D. Geenty, Ann T. Gregory, Mark Nolan, A. Robert Denniss, Salvatore Pepe, Aaron L. Sverdlov, Liza Thomas
- When Cancer and Cardiovascular Disease Intersect: The Challenge and the Opportunity of Cardio-Oncology
- Aaron L. Sverdlov, Bogda Koczwara, Daniel A. Cehic, Robyn A. Clark, Lee Hunt, Stephen J. Nicholls, Liza Thomas, Elysia Thornton-Benko, Leonard Kritharides, Clinical Oncology Society of Australia (COSA)–Cardiac Society of Australia and New Zealand (CSANZ) Cardio-Oncology Working Group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?